Pharvaris (PHVS) Other Non Operating Income (2020 - 2025)
Pharvaris (PHVS) posted Other Non Operating Income of -$4.5 million for Q4 2025, down 262.99% on a QoQ basis from $2.7 million in Q3 2025, and down 168.04% year-over-year from $6.6 million in Q4 2024.
Pharvaris (PHVS) Other Non Operating Income (2020 - 2025) Analysis & Trends
Pharvaris' Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$4.5 million for Q4 2025.
- Quarterly Other Non Operating Income fell 168.04% year-over-year to -$4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$11.3 million (down 235.67% YoY) and the FY2025 annual result came in at -$11.6 million, down 235.98% from the prior year.
- Other Non Operating Income was -$4.5 million for Q4 2025 at Pharvaris, down from $2.7 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.0 million in Q1 2021 and bottomed at -$5.6 million in Q2 2025.
- A 5-year average of $767034.2 and a median of $1.7 million in 2024 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 20896.33% in 2021, while the deepest fall reached 13639.54% in 2021.
- Pharvaris' Other Non Operating Income stood at $4.8 million in 2021, then declined by 20.05% to $3.8 million in 2022, then plunged by 242.0% to -$5.4 million in 2023, then soared by 221.56% to $6.6 million in 2024, then sank by 168.04% to -$4.5 million in 2025.
- Business Quant data shows PHVS's Other Non Operating Income at -$4.5 million in Q4 2025, $2.7 million in Q3 2025, and -$5.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.47 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | -5.55 Mn |
| Mar 31, 2025 | -4.05 Mn |
| Dec 31, 2024 | 6.57 Mn |
| Sep 30, 2024 | -3.93 Mn |
| Jun 30, 2024 | 5.08 Mn |
| Mar 31, 2024 | 628,156.10 |
| Dec 31, 2023 | -5.40 Mn |
| Sep 30, 2023 | 2.99 Mn |
| Mar 31, 2023 | -108,636.15 |
| Mar 31, 2022 | 3.81 Mn |
| Dec 31, 2021 | 4.76 Mn |
| Sep 30, 2021 | 5.17 Mn |
| Jun 30, 2021 | -2.98 Mn |
| Mar 31, 2021 | 7.02 Mn |
| Dec 31, 2020 | -938,431.07 |
| Sep 30, 2020 | -147,572.54 |
| Jun 30, 2020 | -21,688.85 |
| Mar 31, 2020 | -33,750.73 |